Research News

New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease

Jul 17, 2023, 7:03 AM

A recent study from the lab of the Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease.

Drug studied at UK is 1st disease-modifying therapy in U.S. approved to treat Alzheimer’s

Jul 12, 2023, 7:07 AM

The U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Allison%20Gibson%20Frame%20Grab%20-%202.jpg

Women Making History: UK researcher helps caregivers navigate Alzheimer's challenges

Mar 1, 2023, 7:09 AM

Throughout March, UK is spotlighting Women Making History. These women are leading their fields of research and impacting the lives of Kentuckians. For Allison Gibson, Ph.D., her passion is helping some of the most vulnerable Kentuckians.

Promising Alzheimer's drug being studied at UK's Sanders-Brown Center on Aging receives FDA approval

Jan 30, 2023, 7:05 AM

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab.

Pat Summitt Foundation awards grant to University of Kentucky Sanders-Brown Center on Aging

Jan 27, 2023, 7:09 AM

The Pat Summitt Foundation presented a $25,000 grant to the University of Kentucky's Sanders-Brown Center on Aging (SBCoA) during the UK women’s basketball game against Auburn University on January 26, 2023.

UK's Sanders-Brown among 1st locations testing promising new Alzheimer's drug

Dec 9, 2022, 7:29 AM

Sanders-Brown Center on Aging is now a site for the first-ever clinical trial testing the effect lecanemab has in people with no cognitive symptoms of Alzheimer’s disease but have amyloid present in their brains.

Sanders-Brown researcher receives $1.7 million to study adverse effects of Alzheimer’s drugs

Nov 2, 2022, 7:44 AM

Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.

UK researcher explores multisensory approach as potential treatment for Alzheimer’s patients

Oct 20, 2022, 7:57 AM

The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.

Journal announces UK's Donna Wilcock as new editor-in-chief

Oct 3, 2022, 7:34 AM

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

Sanders-Brown researchers receive $20.5 million from National Institute on Aging

Sep 2, 2022, 8:27 AM

The award exemplifies team science, helping to support 35 researchers across six different labs on four main projects on astrocytes.

Filter News

Unit

News type

Topic

Series